In particular, NLRP3, a member of the NLR family, was found to be crucial in AD pathogenesis, with NLRP3 activation being linked to the exacerbation of Aβ plaque spread37 and tau protein abnormalities38. Here, MAPT is linked to Alzheimer disease.